NanoLogix Inc (NNLX)

[nmbr1stckpckr]

Hmmm....all that for something that is more clearly explained here:

http://www.nanologix.com/press_room/releases/UT_Houston_Clinical_Trial_Update-Internal-Feb-3-2011.html

"Regarding active studies with GBS utililizing NanoLogix technology, we at UT Houston have been very pleased with our initial results. We recently submitted an abstract of the first phase results to the American Society For Microbiology (ASM) and anticipate presenting our data at the annual ASM conference in New Orleans this May. If accepted, this presentation will highlight the first phase of the project which focuses on development of the assay and will form the foundation for the 300-patient clinical trial which is underway."